Where does Feldan Bio Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Feldan Bio Inc. ranks #35,300 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Feldan Bio Inc. hold?

Feldan Bio Inc. holds 7 US utility patents granted between 2017 and 2025, spanning 5 technology areas.

What is Feldan Bio Inc.'s Innovation Score?

Feldan Bio Inc. has an Innovation Score of 41.0 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Feldan Bio Inc. focus on?

Feldan Bio Inc.'s top technology area is C07K (Peptides) with 7 patents, ranking #1,213 of 3,615 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Feldan Bio Inc.'s patent grant rate increasing or decreasing?

Feldan Bio Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Feldan Bio Inc.'s patents?

Feldan Bio Inc.'s patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Feldan Bio Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Feldan Bio Inc.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Feldan ranks #35,300 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#35,300
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.0/100): 21.0
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35300 · Foreign Corporation #35,300 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,300/49,997
PHOTO-FINISH Fdn For Res & Bus…
CPC-NARROW C07K · 5 areas
INNOV-PAR 41.0/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Feldan’s 41.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (18%) Velocity 13.3 pts (32%) Breadth 7.9 pts (19%) Claim depth 12.6 pts (31%)

Qualcomm Incorporated · highest

85
Feldan Bio · this assignee

41
Florida Institute… · near

41
Orckit IP · near

41
Pennsy · near

41
Shanghai XIN QI… · near

41
3D Lighting… · lowest

7

What this shows Feldan's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Feldan?

Each dot is one of Feldan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Feldan’s own 21.0 claims/patent is ABOVE the 11.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Feldan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Feldan's grants concentrate

Feldan Bio Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Feldan sits between Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech. and Fibralign Corporation.

Feldan's three-year grant acceleration

Feldan Bio Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Fdn For Res & Bus…

7
Fedex

7
Federal State Bud…

7
Federal-mogul Sea…

7
Fennec Pharmaceut…

7
Fetch Rewards

7
Figpin Collect Aw…

7
Fibralign

7
Feldan Bio ◀

7

What this shows Feldan holds 7 patents at rank #35,351, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Feldan

By rank, the assignees closest to #35,351 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Feldan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Feldan, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Feldan ranks #1,213 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Shanghai XIN QI Electronic Technology Co., Ltd 41 Florida Institute of Technology, Inc. 41 Orckit IP, LLC 41 Pennsy Corporation 41

Feldan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Feldan Bio Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2018	1	14.3%
2020	1	14.3%
2023	1	14.3%
2024	1	14.3%
2025partial year	2	28.6%

Which technologies does Feldan Bio Inc. patent most?

C07K - Peptides 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Feldan Bio Inc.'s patent record in context - here's where to go next.

Feldan Bio Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #35,300 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Feldan Bio Inc. against Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.